Xiaoping Peng
Impact in
-
- Tryptophan and brain disorders
-
- Gastrointestinal motility and disorders
Papers in
-
- Venous Thromboembolism Diagnosis and Management 3
-
- Acute Myocardial Infarction Research 4
- Cardiovascular Function and Risk Factors 3
- Cardiac Valve Diseases and Treatments 3
- Cardiac Fibrosis and Remodeling 3
Xiaoping Peng
29 papers receiving 288 citations
Peers
Comparison fields: 5 of 77
- Biological Psychiatry 17
- Gastroenterology 24
- Infectious Diseases 50
- Immunology 51
- Cancer Research 34
Countries citing papers authored by Xiaoping Peng
This map shows the geographic impact of Xiaoping Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Peng more than expected).
Fields of papers citing papers by Xiaoping Peng
This network shows the impact of papers produced by Xiaoping Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Peng. The network helps show where Xiaoping Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoping Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 8 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 9 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 8 | |
| 19 | 2021 | 16 | |
| 20 | The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway | 2020 | 3 |
About Xiaoping Peng
Xiaoping Peng is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Applied Microbiology and Biotechnology, Transplantation and Sensory Systems, having authored 35 papers that have together received 295 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (4 papers), Cardiovascular Function and Risk Factors (3 papers), Diet and metabolism studies (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Cardiac Valve Diseases and Treatments (3 papers), Cardiac Fibrosis and Remodeling (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Biological Psychiatry (17 citations), Gastroenterology (24 citations), Infectious Diseases (50 citations), Immunology (51 citations) and Cancer Research (34 citations). Xiaoping Peng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhifeng Zhou, Yuan Luo, Wei Zou, Yao Liu, Yingren Mai, Zhou Liu, Bin Zhao, Li Hu, Haihong Zhou and Huiliang Li. Their work appears in journals such as BMC Cardiovascular Disorders, International Journal of Biological Macromolecules, BMC Endocrine Disorders, Frontiers in Cardiovascular Medicine and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.